SS-31 vs MOTS-C: How MOTS-C Works
MOTS-C’s mechanism in the SS-31 vs MOTS-C comparison is metabolic signaling rather than structural protection. MOTS-C is encoded within the mitochondrial 12S rRNA gene — making it a mitochondria-derived peptide that acts as a retrograde signal from mitochondri
This comparison does not assign a generated winner or score.
- MOTS-C’s mechanism in the SS-31 vs MOTS-C comparison is metabolic signaling rather than structural protection. MOTS-C is encoded within the mitochondrial 12S rRNA gene — making it a mitochondria-derived peptide that acts as a retrograde signal from mitochondria to the nucleus. Published research demonstrates that MOTS-C activates AMPK (the cellular energy sensor), enhances glucose uptake, promotes fat oxidation, and improves insulin sensitivity through effects that extend beyond the mitochondria to whole-body metabolism. PSPeptides carries MOTS-C from $69.99 for this metabolic signaling research.
- A landmark 2015 study published in Cell Metabolism by Lee et al. established MOTS-C as a novel mitochondrial-derived peptide that regulates insulin sensitivity through AMPK-dependent folate cycle inhibition. The research showed MOTS-C reduced high-fat-diet-induced obesity in rodents by approximately 30% and improved insulin sensitivity markers. A 2021 aging study demonstrated that circulating MOTS-C concentrations decline significantly with age — by roughly 35–50% between young adulthood and older age — suggesting a possible link between MOTS-C signaling and the metabolic deterioration observed in aging populations.